Introduction
Semaglutide, a long-acting GLP-1 analogue, continues to be one of the most studied peptides in research laboratories. Known for its receptor-binding activity and biochemical stability, semaglutide has been at the center of new studies this year.

Recent Updates

• Researchers have explored semaglutide’s longer half-life in lab models.

• New analytical data suggests improved receptor specificity.

• Labs are investigating its role in novel GLP-1 pathways.

Why It Matters
With GLP-1 receptor research expanding globally, semaglutide remains a key compound for reproducible results.

Polygon Peptides Advantage
Our semaglutide is HPLC-tested with ≥99% purity and COAs available upon request, ensuring researchers get reliable and verifiable material.